Effect of Platelet Inhibition According to Clopidogrel Dose in Patients With Chronic Kidney Disease
Optimizing Aspirin and Clopidogrel Therapy (BOchum CLopidogrel and Aspirin Plan)
Platelet Inhibition of Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients After Elective Percutaneous Coronary Intervention
Multiple Electrode Aggregometry & Clopidogrel Resistance
Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction (AMI) Patients According to CYP2C19 Polymorphism
† Study has passed its completion date and status has not been verified in more than two years.